血清胱抑素C对肾功能正常的NSTE—ACS患者危险分层的评估价值(5)
[16] Lee M，Saver JL，Huang WH，et al. Impact of elevated cystatin C level on cardiovascular disease risk inpredominantly high cardiovascular risk populations：a meta-analysis [J]. Circ Cardiovasc Qual Outcomes，2010，3(6)：675-683.
[17] Luo J，Wang LP，Hu HF，et al. Cystatin C and cardiovascular or all-cause mortality risk in the general population：A meta-analysis [J]. Clin Chim Acta，2015，450(10)：39-45.
[18] Silva D，Cortez-Dias N，Jorge C，et al. Cystatin C as Prognostic Biomarker in ST-Segment Elevation Acute Myocardial Infarction [J]. Am J Cardiol，2012，109(10)：1431-1438.
[19] Windhausen F，Hirsch A，Fischer J，et al. Cystatin C for enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponin T [J]. Clin Chem，2009，55(6)1118-1125.
[20] Bassand JP，Hamm CW，Ardissino D，et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes [J]. Eur Heart J，2008， 28(2)：1598-1660.
(收稿日期：2017-03-21 本文編辑：张瑜杰), 百拇医药(陈超 徐通达)
[17] Luo J，Wang LP，Hu HF，et al. Cystatin C and cardiovascular or all-cause mortality risk in the general population：A meta-analysis [J]. Clin Chim Acta，2015，450(10)：39-45.
[18] Silva D，Cortez-Dias N，Jorge C，et al. Cystatin C as Prognostic Biomarker in ST-Segment Elevation Acute Myocardial Infarction [J]. Am J Cardiol，2012，109(10)：1431-1438.
[19] Windhausen F，Hirsch A，Fischer J，et al. Cystatin C for enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponin T [J]. Clin Chem，2009，55(6)1118-1125.
[20] Bassand JP，Hamm CW，Ardissino D，et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes [J]. Eur Heart J，2008， 28(2)：1598-1660.
(收稿日期：2017-03-21 本文編辑：张瑜杰), 百拇医药(陈超 徐通达)